The Chair of the 2019 Sales Awards, David Garmon-Jones, shares his thoughts on what makes this competition such an exciting and worthwhile experience.
6th August 2019
For those who were vaccinated the risk of suffering a stroke was 16% lower than those who weren’t.
5th August 2019
GCT is a rare tumour that affects the synovium and tendon sheaths.
5th August 2019
The decision comes from positive cardiovascular outcomes and renal data from the Phase III DECLARE-TIMI 58 trial.
5th August 2019
The collaboration will combine Sosei’s structure-based drug design capabilities with Takeda’s discovery, development and therapeutic area expertise.
5th August 2019
The 20 hospitals set to be upgraded at a cost of £850 million have been announced.
5th August 2019
With the entries for the 2019 competition well underway, PharmaTimes have seen a large number of industry leading companies putting their best teams and individuals forward.
5th August 2019
Bempegaldesleukin, Nektar's lead immuno-oncology candidate, is an investigational CD122-preferential IL-2 pathway agonist.
2nd August 2019
It is the only monthly anti-IL5 biologic approved in Europe that patients can take home.
2nd August 2019
Patients with Lynch syndrome have an increased risk of colorectal cancer.
2nd August 2019
The decision is based on evidence from the COMPASS study, which was stopped early after meeting its primary efficacy endpoint.
2nd August 2019
The NHS Confederation has penned a letter to Boris Johnson, the UK’s new prime minister.
1st August 2019
The amendment extends the original contract by six months to June 2020.
1st August 2019
GSK has a controlling equity interest of 68% and Pfizer has an equity interest of 32% in the venture.
1st August 2019
The success marks the second Phase III clinical trial in which Kisqali met overall survival.
1st August 2019
